Salvatore Salamone is the founder of Saladax Biomedical. Saladax Biomedical has raised $8M in total funding. Latest round: Series C.
Salvatore J. Salamone, Ph.D., is the CEO of Saladax Biomedical, a commercial-stage therapeutics developer specializing in oncology and diagnostic testing. He received the Dr. C.E. Pippenger Award in 2021 and led the company through the FDA authorization of its clozapine test in the US in 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library